@ARTICLE{
author={Wanner Christoph,...,Lalic Nebojsa M,...,(broj koautora 27)},
year={2026},
title={From global guidelines for cardio-kidney-metabolic diseases management to national implementation: perspectives from the guideline workshop taskforce},
journal={CARDIOVASCULAR DIABETOLOGY},
volume={25},
number={1},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Davies Melanie J,Drexel Heinz,Jornayvaz Francois R,Pataky Zoltan,Seferovic Petar M,Wanner Christoph},
year={2022},
title={Cardiovascular outcomes trials: a paradigm shift in the current management of type 2 diabetes},
journal={CARDIOVASCULAR DIABETOLOGY},
volume={21},
number={1},
pages={-},
document_type={Review},
} 

@ARTICLE{
author={Locatelli Francesco,Spasovski Goce B,Dimkovic Nada B,Wanner Christoph},
year={2016},
title={Long-Term Evaluation of Colestilan in Chronic Kidney Disease Stage 5 Dialysis Patients with Hyperphosphataemia},
journal={BLOOD PURIFICATION},
volume={41},
number={4},
pages={247-253},
document_type={Article},
} 

@ARTICLE{
author={Hertel Joachim,Locatelli Francesco,Spasovski Goce B,Dimkovic Nada B,Wanner Christoph},
year={2015},
title={Randomized, Double-Blind, Placebo-Controlled, Withdrawal Study of Colestilan after Dose Titration in Chronic Kidney Disease Dialysis Patients with Hyperphosphatemia},
journal={NEPHRON},
volume={130},
number={4},
pages={229-238},
document_type={Article},
} 

@ARTICLE{
author={Locatelli Francesco,Spasovski Goce B,Dimkovic Nada B,Wanner Christoph,Dellanna Frank,Pontoriero Giuseppe},
year={2014},
title={The effects of colestilan versus placebo and sevelamer in patients with CKD 5D and hyperphosphataemia: a 1-year prospective randomized study},
journal={NEPHROLOGY DIALYSIS TRANSPLANTATION},
volume={29},
number={5},
pages={1061-1073},
document_type={Article},
}